PeptiDream: change report
PeptiDream: Confirmation letter
PeptiDream: Corrected Financial Report - 18th Term (2023/01/01 - 2023/12/31)
PeptiDream: Large shareholding reports (special exception share certificates, etc.)
PeptiDream: Change report (exemption share certificates, etc.)
PeptiDream: Confirmation letter
PeptiDream: Mid-term report - 19th period (01/01/2024-12/31/2024)
PeptiDream: Consolidated financial results for the six months ended June 30, 2024 [IFRS]
PeptiDream: 2Q of the fiscal year ending December 2024, financial results announcement (IFRS) (consolidated)
PeptiDream: Announcements of individual stocks: Peptide Dream has received a milestone fee for the second program of peptide-drug conjugates (PDC) joint research and development with Novartis.
PeptiDream: (Revised Disclosure) PeptiDream announces expansion of peptide discovery partnership with Novartis AG.
PeptiDream: Announcements of individual stocks regarding the expansion of partnership with Novartis in peptide drug discovery (progress of disclosure matters).
PeptiDream: Confirmation letter
PeptiDream: Quarterly Report - 19th Quarter 1 (2024/01/01 - 2024/03/31)
PeptiDream: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
PeptiDream: Consolidated financial results for the three months ended March 31, 2024 [IFRS]
PeptiDream: PeptiDream announces upward revisions to financial forecasts
PeptiDream: Notice regarding upward revisions to earnings forecasts
PeptiDream: Articles of Incorporation 2023/03/01
PeptiDream: Notice regarding expansion of partnership with Novartis in peptide drug discovery
No Data
No Data